Like Minded People
2.247
PORTFOLIO ITEMS
158
FEATURED ARTICLES
28.731
DAILY SEARCHES
Like Minded People
2.247
PORTFOLIO ITEMS
158
FEATURED ARTICLES
28.731
DAILY SEARCHES
Recently Posted Blogs
- All
- Analytical Discussion
AstraZeneca today announced a collaboration with the Montreal Heart Institute (MHI) in Quebec, Canada, to search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes, their complications and treatment outcomes. This is one of the largest such screens of its type to date and will drive understanding of the biological mechanisms underlying these conditions […]
F2 parameter is widely used parameter in drug dissolution testings where it is often used to predict similarity of two dissolution profiles. F2 factor In short, two profiles are considered identical when f2=100. An average difference of 10% at all measured time points results in a f2 value of 50. A public standard of f2 value between 50-100 to indicate similarity […]
The FDA cleared the Cepheid Xpert MTB/RIF Assay to help physicians determine if patients with suspected tuberculosis (TB) can be removed from airborne infection isolation. This expanded use allows healthcare providers to use one or two negative Xpert MTB/RIF Assay test results to help them determine whether a patient showing signs and symptoms of pulmonary TB should continue to be […]
Pharmaceutical Technology‘s 2015 Solid Dosage and Excipients eBook examines how advances in technology, equipment, excipients, analytical techniques, software, and manufacturing practices are facilitating the development, scale up, manufacturing, efficacy, and delivery of solid- and semi-solid dosage forms. Issue topics include: Advances in Tableting Analytical Techniques for Efficient OSD Formulation Improving Pharmaceutical Palatability Improving Efficiency in Hot Melt Extrusion and Spray […]
The new ICH Q3D Guideline for Elemental Impurities has initiated reviews and changes in quality testing programs in bio/pharmaceutical companies around the world. Companies need to assess the risks of potential elemental impurities in their process and materials streams. In this webcast, experts review the requirements of elemental impurities guidelines, practical recommendations to address implementation challenges, and key considerations for […]
Increasing requests from regulatory agencies have focused on evaluation of APIs and drug products during shipment. However, little guidance has been provided on how to address these concerns. This webinar will address these questions and explore approaches to assessing stability of biologic APIs and small molecule drug products throughout shipment. Register free: www.pharmtech.com/pt/stabilitySponsored by Patheon
This webcast invites all pharmaceutical scientists and formulators from R&D and analytical departments that have an interest in the solubilization of poorly soluble drugs, and in understanding the importance of choosing a proper dissolution method in the solubilization tests to reveal the full potential of the tested solubilization method. Register free www.pharmtech.com/dissolutionSponsored by BASF
Strategies and case studies on Systematic and Efficient Analytical Method Development for A Speedy Clinical Product Development presented by experts at Patheon. Learn how to accelerate your first-in-man studies with a deliberate approach to analytical method development for early stage drug products. Register free www.pharmtech.com/efficientSponsored by Patheon
Recently Posted Blogs
- All
- Analytical Discussion
AstraZeneca today announced a collaboration with the Montreal Heart Institute (MHI) in Quebec, Canada, to search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes, their complications and treatment outcomes. This is one of the largest such screens of its type to date and will drive understanding of the biological mechanisms underlying these conditions […]
F2 parameter is widely used parameter in drug dissolution testings where it is often used to predict similarity of two dissolution profiles. F2 factor In short, two profiles are considered identical when f2=100. An average difference of 10% at all measured time points results in a f2 value of 50. A public standard of f2 value between 50-100 to indicate similarity […]
The FDA cleared the Cepheid Xpert MTB/RIF Assay to help physicians determine if patients with suspected tuberculosis (TB) can be removed from airborne infection isolation. This expanded use allows healthcare providers to use one or two negative Xpert MTB/RIF Assay test results to help them determine whether a patient showing signs and symptoms of pulmonary TB should continue to be […]
Pharmaceutical Technology‘s 2015 Solid Dosage and Excipients eBook examines how advances in technology, equipment, excipients, analytical techniques, software, and manufacturing practices are facilitating the development, scale up, manufacturing, efficacy, and delivery of solid- and semi-solid dosage forms. Issue topics include: Advances in Tableting Analytical Techniques for Efficient OSD Formulation Improving Pharmaceutical Palatability Improving Efficiency in Hot Melt Extrusion and Spray […]
Member Activity
-
Pharma Live wrote a new post
The rationale for granting patents for new drugs is to give companies incentives to research new and better drugs. Allowing them a monopoly for a period of time allows drug companies the opportunity to recoup the cost of their...
-
Pharma Live wrote a new post
Last fall, India’s new Prime Minister, Narendra Modi, met with President Obama in Washington. According to the public accounts, the meeting was friendly with both sides hoping for stronger diplomatic and economic ties. The Obama administration was eager to...
-
Pharma Live wrote a new post
In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of using its patent rights to keep generic versions of Toprol-XL off the market in Louisiana. AstraZeneca does have patent coverage, but the...
-
Pharma Live wrote a new post
In a setback to US consumer health behemoth Johnson & Johnson, India’s patent office has rejected an application from Janssen Pharmaceutica NV, the company’s pharma arm, for an intermediate of Rilpivirine, an HIV drug. The patent office’s order came in...
-
Pharma Live wrote a new post
Summary Hedge funds managers are attacking what they see as “weak patents” held by pharmaceutical companies while they are also shorting the stock at the same time.The hedge fund managers patent challenges are controversial because the pharmaceutical industry contends that...
-
Pharma Live wrote a new post
Pfizer Inc. (NYSE:PFE), presently the world’s largest seller of central nervous system (CNS) drugs, may have its future lead challenged by a sharp rise of the biotech giant, Biogen Inc (NASDAQ:BIIB), as per a recent report by GlobalData. Pfizer led...
-
Pharma Live wrote a new post
For over an hour yesterday, as the Senate Judiciary Committee hearing on the recently introduced PATENT Act unfolded, it seemed like we were in patent fantasyland. Except for some predictable comments from the deputy general counsel of pharma giant Bristol-Myers Squibb that any...
-
Pharma Live wrote a new post
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been sued in the US District Court for the District of New Jersey on patent infringement charges by VIVUS, Inc. (NASDAQ:VVUS). The lawsuit comes a month after Teva filed an Abbreviated New Drug...
-
Pharma Live wrote a new post
The controversy surrounding Orexigen Therapeutics OREX -0.20% and its release of interim study data for its Contrave diet pill is quickly escalating. Amid accusations the drug maker misled investors and patients about the safety of its drug, Orexigen is...
-
Pharma Live wrote a new post
Jakarta. Public health activists have called on the government to review a number of key points included in a revised patent bill in order to uphold patients’ rights before the bill passes the House of Representatives this year. Ever since the...
-
Pharma Live wrote a new post
Patents play a key role in encouraging the development of pharmaceutical products. It can take several hundred million dollars to discover, develop, and gain regulatory approval for a new drug, and funding for research is obtained primarily from profits...
-
Pharma Live wrote a new post
SAN FRANCISCO and GENEVA, May 5, 2015 (GLOBE NEWSWIRE) — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing therapeutic and diagnostic products for neurological disorders and orphan indications, announced that it has received a Notice of Allowance...
-
Pharma Live wrote a new post
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China (SIPO) granted a process patent for its novel stem-cell based drug...
-
Pharma Live wrote a new post
GW Pharmaceuticals plc (AIM:GWP) (Nasdaq:GWPH) (“GW”) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 13/075,873, a patent application which covers the use of cannabidivarin (CBDV) for...
-
Pharma Live wrote a new post
Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced that it has been issued Patent No. EP2366775B1, titled “Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy”, by...
-
Pharma Live wrote a new post
ERYTECH (Paris:ERYP) (ADR:EYRYY), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, announces the strengthening of its intellectual property portfolio in the United States with the granting of...
-
Pharma Live wrote a new post
One of the promises of the Human Genome Project was that knowledge of the entirety of the human genetic complement would permit researchers to identify genetic bases for diseases that had been intractable to conventional approaches. While these efforts...
-
Pharma Live wrote a new post
In a potentially promising sign for Western drugmakers, Merck ($MRK) scored a victory in its patent battle with India’s Glenmark Pharmaceuticals over copycats of the drugmaker’s diabetes meds Januvia and Janumet. India’s highest court has blocked the generics company from marketing...
-
Pharma Live wrote a new post
Would-be makers of rare disease meds, rejoice: A 6-month exclusivity extension, proposed last year in Congress, has returned. The 21st Century Cures Act, now under consideration in the House of Representatives, once again includes a measure that would prolong competition-free...
-
Pharma Live wrote a new post
pharmacistThe global orphan drug market is expected to account for 19% of all branded prescription drug sales by 2020, according to a new report. EvaluatePharma estimates drugs for rare diseases could collectively account for $176bn in annual sales in just...
- Load More Posts